Skip to content

STOPOVCA 2.0

Stop Ovarian Cancer 2.0 - STOPOVCA 2.0

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58392
Enrollment
30
Registered
2025-02-18
Start date
2026-05-07
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of ovarian cancer Ovarian cancer

Interventions

The intervention will be the addition of information provision of OS during counselling and the addition of performing OS during a non-gynaecological intra-abdominal surgery for another indication.&nb
A patient decision aid and a toolbox for professionals has been developed.

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Between 35 and 65 years of age- Undergoing cholecystectomy or bariatric surgery- Will have residual ovarian tissue after surgery- Has reached completion of childbearing- Able to understand the written or spoken Dutch language- Gives consent for enrolment in database 

Exclusion criteria

Exclusion criteria: - Under 35 or over 65 years of age- Undergoing  surgery in which currently both ovaries and fallopian tubes would not be preserved- Child wish- Unable to understand the written or spoken Dutch language- Previous bilateral salpingectomy- Previous bilateral salpingo-oophorectomy

Design outcomes

Primary

MeasureTime frame
We will assess the degree of implementation of OS by examining medical files through assessment of the number of women who were eligible for OS, have been offered OS, and underwent OS. Moreover, we will monitor (not examine) the safety of OS during non-gynaecological intra-abdominal surgery performed by surgeons (not gynaecologists) on the level of rate of accomplishment; all intraoperative and postoperative complications; surgery time and length of hospital stay. In addition, experiences of the stakeholders (patients and professionals) with the implementation of OS and the different elements of the implementation strategy will be assessed by focus groups and interviews.

Secondary

MeasureTime frame
-

Countries

Netherlands

Contacts

Public ContactJ. Schauwaert

Radboud Universitair Medisch Centrum

stopovca.verlgyn@radboudumc.nl+31 (0)24 361 53 05

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026